A 59-year-old womandeveloped multiple hepatic tumors 20 years after resection of pheochromocytoma of the left adrenal gland. Thin-needle aspiration biopsy of the tumor at segment 2 of the liver under ultrasound control showed histology compatible to pheochromocytoma. Then, on the basis of the diagnosis of hepatic metastasis of malignant pheochromocytoma, transcatheter arterial embolization (TAE) was performed for the purpose of the treatment of hepatic metastasis. After TAE, the size of the hepatic metastatic lesions was decreased. The present case suggests the necessity of long-term follow-up in pheochromocytomacases. (Internal Medicine 32: 789-794, 1993) 
Introduction
Malignant pheochromocytomahas been reported to be rare, and its prognosis is poor (1) . In addition, it is difficult to distinguish benign tumors from malignant tumors histologically (2, 3) and the diagnosis of malignant pheochromocytoma is usually established by the presence of metastasis in other organs. Here, we present an interesting case in which hepatic metastasis of malignant pheochromocytomawas diagnosed by a thin-needle aspiration biopsy 20 years after a surgical operation of the primary lesion of the left adrenal gland. The patient was asymptomatic, but underwent transcatheter arterial embolization (TAE) for the purpose of the treatment of hepatic metastasis. After TAE, vanilmandelic acid (VMA)levels in the urine were decreased and the hepatic metastatic lesions showed a significant decrease in size.
Case Report
A 39-year-old womanunderwent a surgical operation to remove a pheochromocytomaof the left adrenal gland which was accompanied by hypercatecholaminemia and paroxysmal hypertension in 1 972, and the clinical course was uneventful for 20 years thereafter. She began to feel epigastric discomfort in September 1 99 1. Ultrasound (US) examination of the abdomen revealed a hepatic tumor at segment 2 (S2) of the liver about 4 cmin size, and she was admitted to our hospital for further evaluation of the tumor. The patient was 152.2 cm tall and weighed 42.8 kg. Her blood pressure was 108/67 mmHgand pulse rate 78/min and regular. The palpebral conjunctiva was not anemic and the bulbar conjunctiva wasnot icteric. The results of the examination of her head, neck, and chest were normal. The abdomen was flat, soft, and no mass was palpable. Laboratory data on admission is shown in Table 1 . Abnormal data in the blood chemistry are underlined. Serum total-cholesterol levels were increased and indocyanine green dye plasma disappearance rate (KICG) was decreased. Other data including all tumor markers were within normal limits. The endocrinological examination revealed that plasma and urine catecholamines were almost within normal limits, but urinary excretion of the metabolites; metanephrine, normetanephrine, and VMAwas elevated ( Table 2 , data before TAE). USexamination of the abdomenshowed a tumor with halo at S2 of the liver (Fig. 1) . It measured about 4 cm in diameter, and the internal echo was uniform and high. Contrast enhanced computerized tomography (CT) of the abdomen showed a round tumor surrounded by an enhanced ring and hepatic parenchyma in the left lobe of the liver (Fig. 2a) Internal Medicine Vol. 32, No. 10 (October 1993) below the first tumor (Fig. 2b) . Magnetic resonance imaging revealed multiple liver tumors. The main tumor in the left lobe of the liver showed a high intensity signal in the Tl-weighted image (Fig. 3a) , and a very high intensity signal in the T2-weighted image (Fig. 3b) . Two other tumors were observed in the lateral area of the left lobe ( Fig. 3b) , and several minute metastases were also observed in the right lobe in other scans. The tumor appeared to have developed multifocally in the liver, but no other tumor or metastasis was recognized by systemic examinations including US of the thyroid gland, CT of the chest, and scintigraphy of the bone and whole body. In order to establish the diagnosis, a thin needle aspiration biopsy of the tumor at S2 of the liver under US control was performed. Histology of the tumor revealed various shapes of comparatively large cells, which were the findings consistent with pheochromocytoma (Fig. 4) . Electron microscopy revealed tumor cells, which were full of neurosecretory granules, approximately 250 nm in diameter, and these findings were also consistent with those of pheochromocytoma (Fig. 5 ). According to the findings, the tumor was diagnosed as hepatic metastasis of malignant pheochromocytoma, and angiography was performed for the purpose of the treatment. Angiographyof the celiac artery revealed two tumor stains in the left lobe and multiple minute tumor stains in the right lobe (Fig. 6 ). Because these tumors were hypervascular, intraarterial chemotherapy using iodine addition products of the ethylesters of the fatty acids obtained from poppyseed oil (Lipiodol) suspension of anti-cancer agents, and TAEwere performed. A suspension of aclarubicin hydrochloride, mitomycin C, and Lipiodol was injected in the tumor through the left and right hepatic arteries, and small pieces of gelatin sponge (Spongel, Yamanouchi Chemical Co., Ltd.) were injected into both of the arteries.
After the treatment, transient hypertension ( 1 90/1 38 mmHg maximum)and tachycardia (130/min maximum)were observed. The changes in catecholamines and their metabolites before and after TAEare shown in Table 2 . Three days after TAE, plasma and urine catecholamines and their metabolites were increased transiently, but all were decreased and changed to within normal limits after 30 days. Markedaccumulation of Lipiodol in the maintumors and minute metastases were observed in the follow-up CT 3 weeks after TAE (Fig. 7) . Six months after TAE, the size of the tumor at S2 was decreased to about 2 cm on USand the otherlesions also showeda significant size decrease on CT (Fig. 8) . Thereafter she has notrelapsed and had a good clinical course to date.
Discussion
Most pheochromocytoma have been reported to be benign, while approximately 10% of them are malignant (1) (2) (3) . It is difficult to distinguish histologically benign tumors from malignant tumors, since even benign pheochromocytomasometimes show cellular dysplasia (2, 3) . Diagnosis of malignant Metastasis of pheochromocytomaoften occurs in the bone (4, 5) , the liver, and lymph nodes, in a manner similar to neuroblastoma. In the present case, the liver metastasis is thought to be the sole extra-adrenal lesion at present. The period of recurrence after the first surgery of malignant pheochromocytoma has been described to be long. Mahoney and Harrison (6) reported that the average period of recurrence after the first surgery was 8 years (ranging from 3 years to 15 years) in 7 cases of malignant pheochromocytoma: 3 cases were diagnosed as malignant and 4 cases were benign according to the first histological examination. They emphasized the importance of continued periodical observations of the clinical course long after the first treatment. Six cases of metastasis in nonchromaffin tissues of malignant pheochromocytoma after the resection of the primary lesion have been reported in the Japanese literature (7-1 1), and all of the cases were diagnosed as benign according to the first histological examination. The period before recurrence ranged from 7 to 18 years. It is not clear whenthe hepatic metastasis occurred in the excretion of inactive metabolites, normetanephrine and metanephrine generated by catechol-o-methyltransferase and the slight increase in the plasma noradrenaline concentration suggest an accelerated inactivation of catecholamines in the tumor in the present case. It is also interesting to note that the biological character of the tumor changed in the present case;
the primary tumor had hypercatecholaminemia with paroxysmal hypertension, but the hepatic metastatic lesions did not have this characteristic.
TAEfor the hepatic metastasis of pheochromocytoma has been reported in 2 cases and were shownto be effective from the viewpoint of decreases in catecholamines and tumor size (14, 15) . Decreases in urinary VMAafter TAEand a high accumulation of Lipiodol in the tumors were suggested to be effective in the present case, and the main tumors actually decreased in size after TAE.In the present case, transient hypertension and tachycardia, which seemed to be due to transient hypercatecholaminemia, appeared after TAE.These symptomsresponded to medical treatment (a à"B-blocker and Ca++ antagonist oral administration) and recovered after several days. As in the present case, at the time of TAE,attention to hypercatecholaminemia due to necrosis of the tumor maybe of necessity.
In summary,the present case suggests that it is quite important to carefully follow-up patients with pheochromocytoma even after surgical removal of the primary lesion, because of difficulties in distinguishing benign pheochromocytoma and malignant pheochromocytoma only by histological findings and because of quite long post-operative period before recurrence. In the case of clinically asymptomaticpheochromocytoma like the present case, it is necessary to carry out periodical endocrinological examinations including metabolite analyses and imaging examinations of the whole body using US, CTand scintigraphy.
